98%
921
2 minutes
20
Background: In a warming world, it is generally accepted that increasing temperatures affect human health. In many regions of the world, however, these effects are poorly understood. To address this issue in Chile, we estimated the potential change in all-cause and cardiovascular and temperature-related (CVT) mortality and hospitalisations associated with four different climate scenarios by region.
Methods: Using Chilean health data and ERA5 reanalysis data, we modelled the relationship between historical health outcomes and monthly temperature indices using Generalised Additive Models. After evaluating the models' predictive performance, we used them to estimate changes in health outcomes associated with bias-adjusted climate projections representing four scenarios: short-term (2031-2060) and long-term (2061-2090) periods under both Representative Concentration Pathways (RCPs) 2.6 and 8.5.
Findings: Scenario-based health outcomes show clear north-south variations. Compared to historical levels, all-cause mortality increases by ∼1.5% in northern regions but decreases by ∼1% in southern regions across scenarios. CVT mortality decreases (0.2-3.6%), especially in the south; however, Arica and Tarapacá in the north show sharp increases (up to 30%) under warmer scenarios. Conversely, all-cause and CVT hospitalisations increase in northern/central regions (higher in summer, lower in winter), while southern/austral regions show slight decreases (∼1%).
Interpretation: These findings highlight the need for region-specific analyses and public health strategies in Chile. Northern regions might require plans that reduce the risk of heat-related mortality and morbidity, while southern regions might adjust healthcare services because of potential shifts in healthcare needs.
Funding: National Agency for Research and Development, Chile and University College London, UK.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12211848 | PMC |
http://dx.doi.org/10.1016/j.lana.2025.101151 | DOI Listing |
JPEN J Parenter Enteral Nutr
September 2025
Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia.
Background: Hospitalized patients may require nutrition support because of inadequate intake or impaired gut function. Enteral nutrition is preferred over parenteral nutrition because of fewer complications and earlier return of gut function. This study describes peripheral parenteral nutrition (PPN) use in an Australian tertiary center, evaluating its indications, incidence of adverse effects, and outcomes without the support of a nutrition support service.
View Article and Find Full Text PDFWounds
August 2025
Solventum, Maplewood, MN, USA.
Background: Initially limited to inpatient use, negative pressure wound therapy (NPWT) is now frequently used in community settings. However, complexities in wound management step-down strategies in the United Kingdom, including regional variations in referral processes, lack of consensus on funding criteria, and limited availability of NPWT units, have led to extended hospital length of stay (LOS) for patients ready for discharge but still needing NPWT. Single-use NPWT (sNPWT) can serve as a bridge between hospital and community NPWT.
View Article and Find Full Text PDFBackground: This retrospective analysis is a derivative cohort study based on a prior retrospective investigation by this author group.
Objective: To assess the effect of the number of cellular and/or tissue-based product (CTP) applications on healing outcomes and wound area reduction (WAR) rates in patients with chronic wounds of multiple etiologies.
Methods: Data from a multicenter private wound care practice electronic health record database were analyzed for Medicare patients receiving CTPs from January 2018 through December 2023.
Wounds
August 2025
Department of Nursing, Federal University of Ceará, Ceará, Brazil.
Background: Diabetic foot ulcers (DFUs) are a major clinical challenge, particularly among patients with refractory ulcers, that often lead to severe complications such as infection, amputation, and high mortality. Innovations supported by strong clinical evidence have the potential to improve healing outcomes, enhance quality of life, and reduce the economic burden on individuals and health care systems.
Objective: To describe the design of the concurrent optical and magnetic stimulation (COMS) therapy Investigational Device Exemption (IDE) study for refractory DFUs (MAVERICKS) trial.